Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 2 Results

  1. 1
    803792

    A warning to Latin America.

    Trueman P

    In: Santamaria J, Richards P, Gibbon W, eds. The dignity of man and creative love: selected papers from the Congress for the family of the Americas, Guatemala, July 1980. New Haven, Connecticut, Knights of Columbus, 1980. 188-95.

    The USAID (U.S. Agency for International Development) has since 1960 promoted abortion worldwide, without concern for the laws, customs, or mores of foreign lands. USAID still promotes the sale and the use of Depo-Provera in Latin America. Depo-Provera, a drug that acts as a contraceptive and abortifacient, is considered by the U.S. Food and Drug Administration to be unsafe for birth control in the U.S. USAID also promotes the sale and the use of the Dalkon Shield type of IUD, which was recalled in the U.S. in 1975 for its hazardous side effects. Moreover, USAID supports abortion research worldwide; for example, there are 3 main USAID funded university research projects in the U.S., beside the London-Based IPPF, and the Boston-based Pathfinder Fund. It is about time that the American people, and the Prolife movement in particular, realize USAID's abortion activities, and act to have Congress pass the Helms Amendment of 1973, which intented to rid USAID of any involvement in abortion related activities.
    Add to my documents.
  2. 2
    802775

    The Dalkon Shield IUD.

    International Planned Parenthood Federation [IPPF]. International Medical Advisory Panel [IMAP]

    IPPF Medical Bulletin. 1980 Dec; 14(6):3.

    The Dalkon Shield IUD was introduced to the list of contraceptives being distributed to developing countries by IPPF (International Planned Parenthood Federation) in 1973. By 1974, doubts had arisen about the safety of the Dalkon Shield and several cases of maternal mortality and sepsis in Dalkon Shield users had been reported. In 1974, IPPF stopped supplying Dalkon Shields to its affiliates. During the 1973-74 period of distribution, IPPF had distributed approximately 300,000 of the Shields in 41 countries. Almost 1/2 that amount had already been inserted. The position of IPPF's IMAP (International Medical Advisory Panel) on any relationship existing between use of IUDs and pelvic inflammatory disease is as follows as of 1980: 1) infection with actinomycosis makes up only a small component of all the incidents of pelvic inflammatory disease connected with IUDs; 2) the occurrence of pelvic inflammatory disease is not related to the length of use of an IUD; 3) data do not now support the recommendation that inert devices free from major side effects should be removed; and 4) any woman still wearing a Dalkon Shield should have it removed.
    Add to my documents.